Market Value1,010,320,000
Total Holdings40
File Date2019-05-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ICPT / Intercept Pharmaceuticals Inc Put
STRM / Streamline Health Solutions, Inc.
LRMR / Larimar Therapeutics, Inc.
YMTX / Yumanity Therapeutics Inc
ITCI / Intra-Cellular Therapies, Inc. Put
IOVA / Iovance Biotherapeutics, Inc.
BOLD / Boundless Bio, Inc.
ENTA / Enanta Pharmaceuticals, Inc.
/ Array BioPharma, Inc. Call
DERM / Journey Medical Corporation
FOMX / Foamix Pharmaceuticals Ltd.
EPZM / Epizyme Inc
KRYS / Krystal Biotech, Inc.
ONCE / Spark Therapeutics, Inc.
US00163U1060 / AMAG Pharmaceuticals, Inc.
OSMT / Osmotica Pharmaceuticals Plc
ARGX / argenx SE - Depositary Receipt (Common Stock)
GNFT / Genfit S.A.
BHVN / Biohaven Ltd. Put
FGEN / FibroGen, Inc. Put
XLRN / Acceleron Pharma Inc
DERM / Journey Medical Corporation Put
VIRX / Viracta Therapeutics, Inc.
ZGNX / Zogenix Inc
PTGX / Protagonist Therapeutics, Inc.
US60877T1007 / Momenta Pharmaceuticals, Inc.
TPST / Tempest Therapeutics, Inc.
CYTK / Cytokinetics, Incorporated
VYNE / VYNE Therapeutics Inc.
ZYME / Zymeworks Inc.
GBT / Global Blood Therapeutics Inc.
ACAD / ACADIA Pharmaceuticals Inc.
UTHR / United Therapeutics Corporation
US33830X1046 / Five Prime Therapeutics Inc
KURA / Kura Oncology, Inc.
CBAY / CymaBay Therapeutics, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
VRTX / Vertex Pharmaceuticals Incorporated Put
SVRA / Savara Inc.
SAGE / Sage Therapeutics, Inc. Put
ALNY / Alnylam Pharmaceuticals, Inc.
TGTX / TG Therapeutics, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
/ Array BioPharma, Inc.
SLDB / Solid Biosciences Inc. Call
PBYI / Puma Biotechnology, Inc.
AKBA / Akebia Therapeutics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock) Put
SAGE / Sage Therapeutics, Inc. Call
NVAX / Novavax, Inc. Call
NVAX / Novavax, Inc. Put
PTCT / PTC Therapeutics, Inc.
CTMX / CytomX Therapeutics, Inc.
VYGR / Voyager Therapeutics, Inc.